CSPC Pharmaceutical Group(DE:CVG)
€0.960.00 (0.00%)
DE:CVG
CSPC Pharmaceutical Group stock forecast
€0.96
At close:0.00 (0.00%)
CSPC Pharmaceutical Group (CVG) Stock Forecast & Price Target
4 Followers
CVG Analyst Ratings
Strong Buy
10Buy0Hold1Sell
Based on 11 analysts giving stock ratings to CSPC Pharmaceutical Group in the past 3 months
CVG Stock 12 Month Forecast
Average Price Target
EUR 1.60▲(66.33% Upside)Based on 11 Wall Street analysts offering 12 month price targets for CSPC Pharmaceutical Group in the last 3 months. The average price target is EUR 1.60 with a high forecast of EUR 2.21 and a low forecast of EUR 0.91. The average price target represents a 66.33% change from the last price of EUR 0.96.
Past 12 Months12 Month ForecastJan2026Oct2026
HighEUR 2.21
AverageEUR 1.60
LowEUR 0.91
Highest Price TargetHighestEUR 2.21Average Price TargetEUR 1.60Lowest Price TargetLowestEUR 0.91
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
 Unknown AnalystNot Ranked | UBS | EUR 1.35 | buy | 40.46%Upside | Reiterated | 10/28/26 | ||
| Mark Kong CFA | DBS | EUR 1.56 | buy | 63.07%Upside | Initiated | 09/10/26 | ||
| Unknown AnalystNot Ranked | Citic Securities | EUR 2.05 | buy | 114.26%Upside | Reiterated | 08/25/26 | ||
| Chu Wang | Jefferies | EUR 0.91 | sell | -4.77%Downside | Reiterated | 08/24/26 | ||
| Unknown AnalystNot Ranked | CICC | EUR 1.37 | buy | 42.84%Upside | Reiterated | 08/22/26 | ||
| Jill Wu | CMB International Securities | EUR 1.49→EUR 1.53 | buy | 59.98%Upside | Reiterated | 08/21/26 | ||
| Unknown AnalystNot Ranked | CLSA | EUR 2.17 | buy | 126.16%Upside | Reiterated | 08/21/26 | ||
| John Yung | Citi | EUR 1.31→EUR 1.60 | buy | 66.64%Upside | Reiterated | 08/21/26 | ||
| Unknown AnalystNot Ranked | Huatai Securities | EUR 2.21 | buy | 130.44%Upside | Reiterated | 08/21/26 | ||
| Alexis Yan | Morgan Stanley | EUR 1.26 | buy | 30.93%Upside | Reiterated | 08/20/26 | ||
| Unknown AnalystNot Ranked | Guosheng Securities | EUR 1.53 | buy | 59.62%Upside | Reiterated | 08/19/26 | ||
| Unknown AnalystNot Ranked | Daiwa | EUR 1.26 | buy | 30.93%Upside | Reiterated | 08/12/26 | ||
| Unknown AnalystNot Ranked | Nomura | EUR 1.18 | buy | 22.72%Upside | Reiterated | 07/24/26 | ||
| Unknown AnalystNot Ranked | HSBC | EUR 1.06 | buy | 10.10%Upside | Reiterated | 07/10/26 | ||
| Unknown AnalystNot Ranked | BOCOM International Holdings Company | EUR 0.92 | hold | -4.18%Downside | Reiterated | 06/02/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Unknown AnalystUBSNot Ranked | BuyReiteratedEUR 1.35 | 10/28/26 | 40.46%Upside | ||
| Mark Kong CFADBS | BuyInitiatedEUR 1.56 | 09/10/26 | 63.07%Upside | ||
| Unknown AnalystCitic SecuritiesNot Ranked | BuyReiteratedEUR 2.05 | 08/25/26 | 114.26%Upside | ||
| Chu WangJefferies | SellReiteratedEUR 0.91 | 08/24/26 | -4.77%Downside | ||
| Unknown AnalystCICCNot Ranked | BuyReiteratedEUR 1.37 | 08/22/26 | 42.84%Upside | ||
| Jill WuCMB International Securities | BuyReiteratedEUR 1.49→EUR 1.53 | 08/21/26 | 59.98%Upside | ||
| Unknown AnalystCLSANot Ranked | BuyReiteratedEUR 2.17 | 08/21/26 | 126.16%Upside | ||
| John YungCiti | BuyReiteratedEUR 1.31→EUR 1.60 | 08/21/26 | 66.64%Upside | ||
| Unknown AnalystHuatai SecuritiesNot Ranked | BuyReiteratedEUR 2.21 | 08/21/26 | 130.44%Upside | ||
| Alexis YanMorgan Stanley | BuyReiteratedEUR 1.26 | 08/20/26 | 30.93%Upside | ||
| Unknown AnalystGuosheng SecuritiesNot Ranked | BuyReiteratedEUR 1.53 | 08/19/26 | 59.62%Upside | ||
| Unknown AnalystDaiwaNot Ranked | BuyReiteratedEUR 1.26 | 08/12/26 | 30.93%Upside | ||
| Unknown AnalystNomuraNot Ranked | BuyReiteratedEUR 1.18 | 07/24/26 | 22.72%Upside | ||
| Unknown AnalystHSBCNot Ranked | BuyReiteratedEUR 1.06 | 07/10/26 | 10.10%Upside | ||
| Unknown AnalystBOCOM International Holdings CompanyNot Ranked | HoldReiteratedEUR 0.92 | 06/02/26 | -4.18%Downside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering CSPC Pharmaceutical Group
3 Months
Success Rate10/16 ratings generated profit
63%
Average Return
+11.11%
Copying Jill Wu's trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +11.11% per trade.
1 Year
Success Rate11/16 ratings generated profit
69%
Average Return
+26.26%
Copying Jill Wu's trades and holding each position for 1 Year would result in 68.75% of your transactions generating a profit, with an average return of +26.26% per trade.
2 Years
Success Rate14/16 ratings generated profit
88%
Average Return
+43.82%
Copying Jill Wu's trades and holding each position for 2 Years would result in 87.50% of your transactions generating a profit, with an average return of +43.82% per trade.
CVG Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 8 | 7 | 7 | 7 | 1 |
| Buy | 7 | 9 | 8 | 5 | 1 |
| Hold | 1 | 1 | 0 | 0 | 0 |
| Sell | 2 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 18 | 18 | 16 | 13 | 2 |
In the current month, CVG has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CVG average Analyst price target in the past 3 months is 1.60.
CVG Financial Forecast
HighEUR 0.02
ConsensusEUR 0.01
LowEUR 0.00
CVG Earnings Forecast
Next quarter’s earnings estimate for CVG is EUR 0.01 with a range of EUR 0.00 to EUR 0.02. The previous quarter’s EPS was EUR 0.06. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighEUR 934M
ConsensusEUR 901M
LowEUR 841M
CVG Sales Forecast
Next quarter’s sales forecast for CVG is EUR 901.13M with a range of EUR 841.36M to EUR 934.32M. The previous quarter’s sales results were EUR 2.44B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
CVG Stock Forecast FAQ
What is DE:CVG’s average 12-month price target, according to analysts?
Based on analyst ratings, CSPC Pharmaceutical Group’s 12-month average price target is €1.60.
What is DE:CVG’s upside potential, based on the analysts’ average price target?
CSPC Pharmaceutical Group has 66.33% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CSPC Pharmaceutical Group a Buy, Sell or Hold?
CSPC Pharmaceutical Group has a consensus rating of Strong Buy, which is based on 10 buy ratings, 0 hold ratings and 1 sell ratings.
What is CSPC Pharmaceutical Group’s share price target?
The average share price target for CSPC Pharmaceutical Group is €1.60. This is based on 11 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €2.21, and the lowest forecast is €0.91. The average share price target represents a 66.33% increase from the current price of €0.959.
What do analysts say about CSPC Pharmaceutical Group?
CSPC Pharmaceutical Group’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Street analysts.
How can I buy shares of CSPC Pharmaceutical Group?
To buy shares of DE:CVG, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
